Archive for November, 2007
Research Looks At How South Asian Populations manage With Cancer
A recent pilot study suggests that there are differences in the way ethnic groups manage with cancer, and a researcher at the University of Leicester, funded by the Leicestershire and Rutland charity Hope Against Cancer, is to investigate that further.
Karen Lord, who holds the first Nursing Fellow…
NHS On Sound Financial Footing To Plan For The Future, UK
The NHS is forecasting a financial surplus for that financial year with the huge majority of NHS trusts in balance, the division of Health announced recently.
This position allows NHS organisations to plan better for the future, accelerate delivery on key priorities, and invest in new services for …
10th ESSM Congress Most Successful Ever - by 2,100 Specialists Gathered In Lisbon by Four Days
The 10th Congress of the European Society for Sexual Medicine closed on the last day registering the highest number of participations ever.
The number of participants at that year’s congress represented an increase of 20% last year’s. In all 2,132 specialists representing 43 countries w…
VYVANSE Demonstrates Significant Efficacy For Treatment Of ADHD For Up To 12 Hours After Administration
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announced that Biological Psychiatry published the results of a study showing VYVANSE™ (lisdexamfetamine dimesylate), the first prodrug stimulant for the treatment of Attention Deficit Hyperactivity Diso…
Thomson Scientific Publishes Its 3rd Quarter Issue Of The Ones To Watch Reviewing The Most Promising Drugs In The Pharmaceutical Pipeline
Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of data solutions to the worldwide research and business communities, has issued its quarterly The Ones-to-Watch report. It provides expert insight into the five most promising drugs entering each new phas…
Shared Facilities, Resources And Programs To Further Stem Cell Research
Research institutions across Southern California have joined forces to advance stem cell research by establishing the Southern California Stem Cell Scientific Collaboration (SC3). Members of the collaboration include the University of Southern California, Childrens Hospital Los Angeles, City of Hope…
Astrazeneca Receives First European Approval For Nexium(R) In Pediatric Gerd
AstraZeneca announced that it has received Swedish Medical Products Agency (MPA) approval for use of Nexium(R) (esomeprazole) in children aged 1-11 years with gastroesophageal reflux disease (GERD) in the reference member state of Sweden, with other European Union nations expected to follow.1
Nexiu…
